2Doç Dr., Beyoğlu Göz Eğitim ve Araştırma Hastanesi, Göz, İstanbul - TÜRKİYE Purpose: To evaluate effi ciency and safety of 577-nm subthreshold yellow laser on treatment of chronic central serous chorioretinopathy (CSCR).
Method: Twelve eyes of 12 patients with CSCR were included in this retrospective study. Patients were seen at month1 and month3 after treatment. Best-corrected visual acuity (BCVA), central macular thickness (CMT), subfoveal choroidal thickness (SCT), and height of subretinal fluid were compared before and after treatment.
Results: The mean age was 44.6±13.4 years. 4 patients were female and 8 patients were male. The mean times between patient?s symptoms started and the laser treatment was 7.4±1.7 months. The mean BCVA was 0.23 ± 0.13 logMAR at baseline and changed to 0.21 ± 0.13 logMAR at month3 (P=0.43). The mean CMT was 400±93 ?m at baseline and changed to 364±103 ?m at month3 (P=0.29). The mean SCT was 418±89 ?m at baseline and changed to 430±76 ?m at month3 (P=0,14). The mean height of subretinal fl uid was 243±97 ?m at baseline and changed to 151±112 ?m at month3 (P=0,01).
Conclusion: The effi ciency of 577-nm subthreshold yellow laser treatment for chronic central serous chorioretinopathy was found limited. The anatomic improvement has been achieved in most of the cases, however the functional results was not successful.
Keywords : chronic central serous chorioretinopathy, micropulse 577-nm subthreshold yellow laser